In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 2, 2009, Pages 353-356

  Soriano, Francisco ^a   Huelves, Lorena ^a   Naves, Plinio ^a   Rodríguez Cerrato, Violeta ^a   del Prado, Gema ^a   Ruiz, Vicente ^a   Ponte, Carmen ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Bactericidal; Device related infections; Eradication; Polystyrene; Resistance

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; MOXIFLOXACIN; POLYSTYRENE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOFILM; CONTROLLED STUDY; CORYNEBACTERIUM UREALYTICUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; URINE;

ANTI-BACTERIAL AGENTS; BIOFILMS; CORYNEBACTERIUM; CORYNEBACTERIUM INFECTIONS; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; QUINOLINES; URINE; VANCOMYCIN;

EID: 58849163597     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn491     Document Type: Article

References (26)

1. Soriano F, Ponte C, Santamaría M et al. Corynebacterium group D2 as a cause of alkaline encrusted cystitis: Report of four cases and characterization of the organisms. J Clin Microbiol 1985; 21 788-92.
2. Soriano F, Tauch A. Microbiological and clinical features of Corynebacterium urealyticum: Urinary tract stones and genomics as the Rosetta Stone. Clin Microbiol Infect 2008; 14: 632-43.
3. Soriano F, Ponte C, Galiano MJ. Adherence of Corynebacterium urealyticum (CDC group D2) and Corynebacterium jeikeium to intravascular and urinary catheters. Eur J Clin Microbiol Infect Dis 1993; 12: 453-6.
4. Soriano F, Ponte C, Santamaría M et al. In vitro and in vivo study of stone formation by Corynebacterium group D2 (Corynebacterium urealyticum). J Clin Microbiol 1986; 23: 691-4.
5. Soriano F, Aguado JM, Ponte C et al. Urinary tract infection caused by Corynebacterium group D2. Report of 82 cases and review. Rev Infect Dis 1990; 12: 1019-34.
6. Soriano F, Rodríguez-Tudela JL, Castilla C et al. Treatment of encrusted cystitis caused by Corynebacterium group D2 with norfloxacin, ciprofloxacin, and teicoplanin in an experimental model in rats. Antimicrob Agents Chemother 1991; 35: 2587-90.
7. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-93.
8. Lam J, Chan R, Lam K et al. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980; 28: 546-56.
9. Marrie TJ, Costerton JW. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intra-arterial catheters. J Clin Microbiol 1984; 19: 687-93.
10. Nickel JC, Gristina AC, Costerton JW. Electron microscopy of infected Foley catheter. Can J Surg 1985; 28: 50-4.
11. Chuard C, Lucet JE, Rohner P et al. Resistance of Staphylococcus aureus recovered from infected foreign body in-vivo to killing by antimicrobials. J Infect Dis 1991; 163: 1369-73.
12. Larsen T, Fiehn N-E. Resistance of Streptococcus sanguis biofilms to antimicrobial agents. APMIS 1996; 104: 280-4.
13. Prosser BT, Taylor D, Dix BA et al. Methods for evaluating effects of antibiotics on bacterial biofilm. Antimicrob Agents Chemother 1987; 31: 1502-6.
14. Stewart PS. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob Agents Chemother 1996; 40: 2517-22.
15. Widmer AF, Wiestner A, Frei R et al. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 1991; 35 741-6.
16. Zapardiel J, Nieto E, Soriano F. Urinary tract infections caused by β-lactam-sensitive Corynebacterium urealyticum strains. Eur J Clin Microbiol Infect Dis 1997; 16: 174-6.
17. Soriano F, Ponte C. A case of urinary tract infection caused by Corynebacterium urealyticum and coryneform group F1. Eur J Clin Microbiol Infect Dis 1992; 11: 626-8.
18. Kostenko V, Ceri H, Martinuzzi RJ. Increased tolerance of Staphylococcus aureus to vancomycin in viscous media. FEMS Immunol Microbiol 2007; 51: 277-88.
19. Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria: Approved Guideline M45-A. CLSI, Wayne, PA, USA, 2006.
20. National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Guideline M26-A. NCCLS, Wayne, PA, USA, 1999.
21. Danese PN, Pratt LA, Dove SL et al. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol 2000; 37: 424-32.
22. McLean RJC, Nickel JC, Noakes VC et al. An in vitro ultrastructural study of infectious kidney stone genesis. Infect Immun 1985; 49: 805-11.
23. Santamaría M, Ponte C, Wilhelmi I et al. Antimicrobial susceptibility of Corynebacterium group D2. Antimicrob Agents Chemother 1985; 28: 845-6.
24. Soriano F, Zapardiel J, Nieto E. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob Agents Chemother 1995; 39: 208-14.
25. Evans DJ, Brown MR, Allison DG et al. Susceptibility of bacterial biofilms to tobramycin: Role of specific growth rate and phase in the division cycle. J Antimicrob Chemother 1990; 25: 585-91.
26. Davies DG, Parsek MR, Pearson JP et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998; 280: 295-8.